Related Experiment Video
Updated: Jun 17, 2026

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
Assessment and treatment of cardiac iron overload in thalassemia
A Aessopos1, D Farmakis, A Andreopoulos
1First Department of Internal Medicine, University of Athens Medical School, Laiko Hospital, Athens, Greece. aaisopos@cc.uoa.gr
Insights
Cardiac disease is the leading cause of death in thalassemia major, with iron overload contributing to heart failure. Cardiac magnetic resonance (CMR) is the best method to assess heart iron, guiding tailored chelation therapy.
Area of Science:
- Cardiology
- Hematology
- Medical Imaging
Background:
- Thalassemia major is a severe inherited blood disorder.
- Iron overload is a common complication of thalassemia major due to frequent blood transfusions.
- Iron overload leads to multi-organ damage, particularly affecting the heart and causing heart failure.
Purpose of the Study:
- To highlight the significance of cardiac iron overload in thalassemia major.
- To emphasize the role of Cardiac Magnetic Resonance (CMR) in assessing cardiac iron.
- To underscore the need for individualized chelation therapy based on iron load.
Main Methods:
- Review of current literature on thalassemia major, iron overload, and cardiac complications.
- Discussion of diagnostic methods for cardiac iron, focusing on CMR.
- Analysis of treatment strategies for iron overload, including chelation therapy.
Main Results:
- Cardiac disease is the primary cause of mortality in thalassemia major.
- Cardiac iron accumulation is a major determinant of heart failure in these patients.
- CMR is the gold standard for quantifying cardiac iron load.
- Effective chelation therapy is crucial for preventing and managing cardiac complications.
Conclusions:
- Cardiac iron overload is a critical factor in the morbidity and mortality of thalassemia major.
- Regular monitoring of cardiac iron using CMR is essential for risk stratification.
- Personalized and intensified chelation therapy, guided by CMR findings, can improve cardiac outcomes.
Abstract:
Cardiac disease remains the major cause of death in thalassemia major and iron overload is involved in heart failure development. Cardiac iron load and heart injury are evaluated by different means, among which CMR measurements remain the best method for estimation. In cases of heart iron overload, chelation treatment should be appropriately tailored in terms of intensification.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Myocarditis IV: Nursing Management
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy VI: Nursing Management
Heart Failure VI: Adjunct Therapies
Myocarditis III: Medical Management
